Literature DB >> 6723765

Influence of age on serum protein binding of propranolol.

R Bendayan, J A Pieper, R B Stewart, G J Caranasos.   

Abstract

The extent of propranolol protein binding was determined in three different age groups of healthy drug-free caucasian males. Volunteers selected for study were 6-15 years old, 25-36 years old and 68-76 years old. Ten milliliters of blood were obtained via venipuncture and collected in glass tubes from the subjects after an overnight fast. Binding determinations were performed by equilibrium dialysis using radiolabelled propranolol. Serum albumin and alpha 1-acid glycoprotein concentrations were determined in all subjects by radial immunodiffusion. The results obtained showed wide intersubject variability in the binding ratio of propranolol and serum concentrations of alpha 1-acid glycoprotein. Mean albumin serum concentration was found to be significantly lower in the elderly group as compared to the adult and pediatric groups (p less than 0.02). A positive correlation was found between the binding ratio of propranolol and the serum concentration of alpha 1-acid glycoprotein in all the subjects (r = + 0.66, p less than 0.005). No significant correlation was found between the binding ratio of propranolol and the serum concentration of albumin (r = -0.03, p less than 0.88). These data suggest that the extent of propranolol binding is influenced primarily by serum concentrations of alpha 1-acid glycoprotein and not by differences in age.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6723765     DOI: 10.1007/BF00630294

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Factors affecting drug binding in plasma of elderly patients.

Authors:  S Wallace; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

3.  Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

Authors:  K M Piafsky; O Borgå
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

4.  The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.

Authors:  G H Evans; A S Nies; D G Shand
Journal:  J Pharmacol Exp Ther       Date:  1973-07       Impact factor: 4.030

5.  Meperidine kinetics in man. Intravenous injection in surgical patients and volunteers.

Authors:  L E Mather; G T Tucker; A E Pflug; M J Lindop; C Wilkerson
Journal:  Clin Pharmacol Ther       Date:  1975-01       Impact factor: 6.875

6.  Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction.

Authors:  G Sager; V Hansteen; I Aakesson; S Jacobsen
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

7.  The distribution of bound propranolol between the different human serum proteins.

Authors:  S Glasson; R Zini; P d'Athis; J P Tillement; J R Boissier
Journal:  Mol Pharmacol       Date:  1980-03       Impact factor: 4.436

8.  Disposition of propoxyphene and propranolol in children.

Authors:  J T Wilson; G F Atwood; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1976-03       Impact factor: 6.875

9.  Diphenylhydantoin potency and plasma protein binding.

Authors:  D W Shoeman; D L Azarnoff
Journal:  J Pharmacol Exp Ther       Date:  1975-10       Impact factor: 4.030

10.  The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration.

Authors:  J Feely; J Crooks; I H Stevenson
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

View more
  12 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 2.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

3.  Incorporation of the Time-Varying Postprandial Increase in Splanchnic Blood Flow into a PBPK Model to Predict the Effect of Food on the Pharmacokinetics of Orally Administered High-Extraction Drugs.

Authors:  Rachel H Rose; David B Turner; Sibylle Neuhoff; Masoud Jamei
Journal:  AAPS J       Date:  2017-05-19       Impact factor: 4.009

4.  Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.

Authors:  G Sager; R Jaeger; C Little
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

5.  Stereoselective binding of propranolol in the elderly.

Authors:  P Colangelo; M Chandler; R Blouin; P McNamara
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

Review 6.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

7.  Protein binding predictions in infants.

Authors:  Patrick J McNamara; Jane Alcorn
Journal:  AAPS PharmSci       Date:  2002

Review 8.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

9.  Gallopamil binding to human serum proteins.

Authors:  D R Rutledge; J A Pieper
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 10.  Individual variation in first-pass metabolism.

Authors:  Y K Tam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.